[Progess in the development of VLPs vaccine].
作者信息
Cao Lei, Bi Sheng-Li
出版信息
Bing Du Xue Bao. 2011 Jul;27(4):378-82.
PMID:21874909
Abstract
摘要
相似文献
1
[Progess in the development of VLPs vaccine].
Bing Du Xue Bao. 2011 Jul;27(4):378-82.
2
The application of virus-like particles to human diseases.
Expert Rev Vaccines. 2013 Feb;12(2):99. doi: 10.1586/erv.12.154.
3
Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
Appl Microbiol Biotechnol. 2014 Apr;98(8):3529-38. doi: 10.1007/s00253-013-5485-6. Epub 2014 Jan 12.
4
Special Issue "Virus-Like Particle Vaccines".
Viruses. 2020 Aug 10;12(8):872. doi: 10.3390/v12080872.
5
Genital delivery of virus-like particle and pseudovirus-based vaccines.
Expert Rev Vaccines. 2011 Sep;10(9):1245-8. doi: 10.1586/erv.11.104.
6
[Progress in virus-like particles technique studies].
Zhongguo Yi Miao He Mian Yi. 2009 Apr;15(2):167-73.
7
Virus-like particles: potential veterinary vaccine immunogens.
Res Vet Sci. 2012 Oct;93(2):553-9. doi: 10.1016/j.rvsc.2011.10.018. Epub 2011 Nov 17.
8
Virus like particle-based vaccines against emerging infectious disease viruses.
Virol Sin. 2016 Aug;31(4):279-87. doi: 10.1007/s12250-016-3756-y. Epub 2016 Jul 11.
9
Subviral particle as vaccine and vaccine platform.
Curr Opin Virol. 2014 Jun;6:24-33. doi: 10.1016/j.coviro.2014.02.009. Epub 2014 Mar 21.
10
Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice.
Appl Microbiol Biotechnol. 2013 Dec;97(24):10445-52. doi: 10.1007/s00253-013-5257-3. Epub 2013 Oct 2.
Zotero 插件